There were 612 press releases posted in the last 24 hours and 318,781 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image